Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch.
Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch.
复制标题
DOI:
10.1073/pnas.2202209119
复制
发表时间:
2022-07-19
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
Phospholipase A2 receptor (PLA2R) is the major autoantigen responsible for causing the rare autoimmune kidney disease, membranous nephropathy (MN). PLA2R autoantibodies primarily bind to a dominant epitope located within a 28-amino acid peptide in the cysteine-rich domain of PLA2R. We generated a minimal peptide necessary for binding autoantibodies with high affinity for developing future therapies. We report the high-resolution structure of PLA2R with its domain orientation and define key regions within the domain epitope critical for its immunogenicity in MN. Membranous nephropathy is an autoimmune kidney disease caused by autoantibodies targeting antigens present on glomerular podocytes, instigating a cascade leading to glomerular injury. The most prevalent circulating autoantibodies in membranous nephropathy are against phospholipase A2 receptor (PLA2R), a cell surface receptor. The dominant epitope in PLA2R is located within the cysteine-rich domain, yet high-resolution structure-based mapping is lacking. In this study, we define the key nonredundant amino acids in the dominant epitope of PLA2R involved in autoantibody binding. We further describe two essential regions within the dominant epitope and spacer requirements for a synthetic peptide of the epitope for drug discovery. In addition, using cryo-electron microscopy, we have determined the high-resolution structure of PLA2R to 3.4 Å resolution, which shows that the dominant epitope and key residues within the cysteine-rich domain are accessible at the cell surface. In addition, the structure of PLA2R not only suggests a different orientation of domains but also implicates a unique immunogenic signature in PLA2R responsible for inducing autoantibody formation and recognition.
登录
查看更多内容
DOI:
10.1074/jbc.ra120.016451
发表时间:
2021-01
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Gully BS;Venugopal H;Fulcher AJ;Fu Z;Li J;Deuss FA;Llerena C;Heath WR;Lahoud MH;Caminschi I;Rossjohn J;Berry R
通讯作者:
Berry R
影响因子:
56.9
作者:
Beyer, Mario;Nesterov, Alexander;Breitling, Frank
通讯作者:
Breitling, Frank
影响因子:
6
作者:
Gauckler P;Shin JI;Alberici F;Audard V;Bruchfeld A;Busch M;Cheung CK;Crnogorac M;Delbarba E;Eller K;Faguer S;Galesic K;Griffin S;van den Hoogen MWF;Hrušková Z;Jeyabalan A;Karras A;King C;Kohli HS;Mayer G;Maas R;Muto M;Moiseev S;Odler B;Pepper RJ;Quintana LF;Radhakrishnan J;Ramachandran R;Salama AD;Schönermarck U;Segelmark M;Smith L;Tesař V;Wetzels J;Willcocks L;Windpessl M;Zand L;Zonozi R;Kronbichler A;RITERM study group
通讯作者:
RITERM study group
影响因子:
2.5
作者:
Basham M;Filik J;Wharmby MT;Chang PC;El Kassaby B;Gerring M;Aishima J;Levik K;Pulford BC;Sikharulidze I;Sneddon D;Webber M;Dhesi SS;Maccherozzi F;Svensson O;Brockhauser S;Náray G;Ashton AW
通讯作者:
Ashton AW
DOI:
10.1107/s2059798318006551
发表时间:
2018-06-01
期刊:
Acta crystallographica. Section D, Structural biology
影响因子:
--
作者:
Afonine PV;Poon BK;Read RJ;Sobolev OV;Terwilliger TC;Urzhumtsev A;Adams PD
通讯作者:
Adams PD